These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15755847)

  • 1. The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial.
    van Trotsenburg AS; Vulsma T; van Rozenburg-Marres SL; van Baar AL; Ridder JC; Heymans HS; Tijssen JG; de Vijlder JJ
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3304-11. PubMed ID: 15755847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of early thyroxine treatment on development and growth at age 10.7 years: follow-up of a randomized placebo-controlled trial in children with Down's syndrome.
    Marchal JP; Maurice-Stam H; Ikelaar NA; Klouwer FC; Verhorstert KW; Witteveen ME; Houtzager BA; Grootenhuis MA; van Trotsenburg AS
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2722-9. PubMed ID: 25243574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-thyroxine therapy and growth processes in children with Down syndrome.
    Kowalczyk K; Pukajło K; Malczewska A; Król-Chwastek A; Barg E
    Adv Clin Exp Med; 2013; 22(1):85-92. PubMed ID: 23468266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Median nerve conduction velocity and central conduction time measured with somatosensory evoked potentials in thyroxine-treated infants with Down syndrome.
    van Trotsenburg AS; Smit BJ; Koelman JH; Dekker-van der Sloot M; Ridder JC; Tijssen JG; de Vijlder JJ; Vulsma T
    Pediatrics; 2006 Sep; 118(3):e825-32. PubMed ID: 16923926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity, hospitalization, and medication use and their influence on mental and motor development of young infants with Down syndrome.
    van Trotsenburg AS; Heymans HS; Tijssen JG; de Vijlder JJ; Vulsma T
    Pediatrics; 2006 Oct; 118(4):1633-9. PubMed ID: 17015556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
    van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
    N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the effectiveness of thyroxine and steroids on reduction of neonatal morbidity: outcome at 20 months follow-up.
    Reyes Baez G; Gonzalez AR; Gomez Raspaldo G; Blasini I; Rivera CE
    P R Health Sci J; 2004 Mar; 23(1):9-12. PubMed ID: 15125213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone and folinic acid in young children with Down syndrome: the phase 3 ACTHYF trial.
    Mircher C; Sacco S; Bouis C; Gallard J; Pichot A; Le Galloudec E; Cieuta C; Marey I; Greiner-Mahler O; Dorison N; Gambarini A; Stora S; Durand S; Polak M; Baruchel A; Schlumberger E; Dewailly J; Azar-Kolakez A; Guéant-Rodriguez RM; Guéant JL; Borderie D; Bonnefont-Rousselot D; Blondiaux E; Ravel A; Sturtz FG
    Genet Med; 2020 Jan; 22(1):44-52. PubMed ID: 31281181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cognitive and motor development in toddlers with congenital hypothyroidism diagnosed by neonatal screening.
    van der Sluijs Veer L; Kempers MJ; Wiedijk BM; Last BF; Grootenhuis MA; Vulsma T
    J Dev Behav Pediatr; 2012 Oct; 33(8):633-40. PubMed ID: 23027136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial.
    Uchiyama A; Kushima R; Watanabe T; Kusuda S
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):177-82. PubMed ID: 25153575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trisomy 21 causes persistent congenital hypothyroidism presumably of thyroidal origin.
    van Trotsenburg AS; Kempers MJ; Endert E; Tijssen JG; de Vijlder JJ; Vulsma T
    Thyroid; 2006 Jul; 16(7):671-80. PubMed ID: 16889491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early thyroxine treatment in Down syndrome and thyroid function later in life.
    Zwaveling-Soonawala N; Witteveen ME; Marchal JP; Klouwer FCC; Ikelaar NA; Smets AMJB; van Rijn RR; Endert E; Fliers E; van Trotsenburg ASP
    Eur J Endocrinol; 2017 May; 176(5):505-513. PubMed ID: 28137734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth.
    Jones JH; Gellén B; Paterson WF; Beaton S; Donaldson MD
    Arch Dis Child; 2008 Nov; 93(11):940-4. PubMed ID: 18456702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of amino-acid supplementation, gestational age and time on thyroxine levels in premature neonates.
    Kelleher AS; Clark RH; Steinbach M; Chace DH; Spitzer AR;
    J Perinatol; 2008 Apr; 28(4):270-4. PubMed ID: 18288119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial treatment dose of L-thyroxine in congenital hypothyroidism.
    Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH
    J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age.
    Briët JM; van Wassenaer AG; Dekker FW; de Vijlder JJ; van Baar A; Kok JH
    Pediatrics; 2001 Apr; 107(4):712-8. PubMed ID: 11335749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
    Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
    Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial of home intervention for children with failure to thrive.
    Black MM; Dubowitz H; Hutcheson J; Berenson-Howard J; Starr RH
    Pediatrics; 1995 Jun; 95(6):807-14. PubMed ID: 7539121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.
    Eyal O; Blum S; Mueller R; Smith FO; Rose SR
    Pediatr Blood Cancer; 2008 Nov; 51(5):652-6. PubMed ID: 18623197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.